HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danielle M Amato Selected Research

Gefitinib (Iressa)

7/2008Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danielle M Amato Research Topics

Disease

2Neoplasms (Cancer)
07/2008 - 02/2006
1Carcinoma (Carcinomatosis)
02/2006
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2006
1Glioblastoma (Glioblastoma Multiforme)
02/2006

Drug/Important Bio-Agent (IBA)

1dacomitinibIBA
07/2008
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2008
1Gefitinib (Iressa)FDA Link
07/2008
1pyrimidineIBA
02/2006
1Dihydrotachysterol (AT 10)IBA
02/2006

Therapy/Procedure

1Oral Administration
07/2008